{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T00:40:04Z","timestamp":1749948004283,"version":"3.41.0"},"reference-count":7,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Antibody persistence of a whole-cell pertussis-containing hexavalent vaccine (DTwP-IPV-HB-PRP~T) and its co- or sequential administration with measles, mumps, rubella (MMR) vaccine were evaluated.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Phase III, open-label, randomized, multicenter study in India. Healthy toddlers 12\u201324 months of age who had received DTwP-IPV-HB-PRP~T or separate DTwP-HB-PRP~T+IPV primary vaccination at 6\u20138, 10\u201312 and 14\u201316 weeks of age received a DTwP-IPV-HB-PRP~T booster concomitantly with MMR (N = 336) or 28 days before MMR (N = 340). Participants had received a first dose of measles vaccine. Immunogenicity assessment used validated assays and safety was by parental reports. All analyses were descriptive.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>All participants had prebooster anti-T \u22650.01 IU\/mL and anti-polio 1 and 3 \u22658 1\/dil, and \u226596.5% had anti-D \u22650.01 IU\/mL, anti-HBs \u226510 mIU\/mL, anti-polio 2 \u22658 1\/dil and anti-PRP \u22650.15 \u00b5g\/mL; for pertussis, antibody persistence was similar in each group. Postbooster immunogenicity for DTwP-IPV-HB-PRP~T was similar for each antigen in each group: \u226599.5% of participants had anti-D \u22650.01 IU\/mL, anti-T \u22650.01 IU\/mL, anti-polio 1, 2 and 3 &gt;8 1\/dil, anti-HBs \u226510 mIU\/mL and anti-PRP \u22651 \u00b5g\/mL; for pertussis, vaccine response was similar in each group [72.0%\u201375.9% (anti-PT), 80.8%\u201381.4% (anti-FIM), 77.6%\u201379.5% (anti-PRN), 78.2%\u201380.8% (anti-FHA)]. There was no difference in MMR immunogenicity between groups, and no difference in DTwP-IPV-HB-PRP~T booster immunogenicity based on the primary series. There were no safety concerns.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>DTwP-IPV-HB-PRP~T antibody persistence was similar to licensed comparators. Booster immunogenicity was robust after DTwP-IPV-HB-PRP~T with or without MMR, and MMR immunogenicity was not affected by coadministration with DTwP-IPV-HB-PRP~T.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Clinical Trials Registry India Number:<\/jats:title>\n            <jats:p>CTRI\/2020\/04\/024843.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000004118","type":"journal-article","created":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T19:12:49Z","timestamp":1697656369000},"page":"1128-1135","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Antibody Persistence Following Administration of a Hexavalent DTwP-IPV-HB-PRP~T Vaccine Versus Separate DTwP-HB-PRP~T and IPV Vaccines and Safety and Immunogenicity of a Booster Dose of DTwP-IPV-HB-PRP~T Administered With an MMR Vaccine in Healthy Infants in India"],"prefix":"10.1097","volume":"42","author":[{"given":"Somnath","family":"Mangarule","sequence":"first","affiliation":[{"name":"Sanofi, Lyon, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prashanth","family":"Siddaiah","sequence":"additional","affiliation":[{"name":"Mysore Medical College and Research Institute, Cheluvamba Hospital, Mysore, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anand","family":"Kawade","sequence":"additional","affiliation":[{"name":"Vadu Rural Health Program, King Edward Memorial Hospital Research Centre, Pune, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravi Mandyam","family":"Dhati","sequence":"additional","affiliation":[{"name":"JSS Hospital and Medical College, JSS Academy of Higher Education and Research, Mysore, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inumarthi Vara","family":"Padmavathi","sequence":"additional","affiliation":[{"name":"Victoria Government Hospital, Visakhapatnam, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonali","family":"Palkar","sequence":"additional","affiliation":[{"name":"Bharati Vidyapeeth Deemed University Medical College, Pune, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virendranath","family":"Tripathi","sequence":"additional","affiliation":[{"name":"Prakhar Hospital Pvt Ltd, Kanpur, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raghvendra","family":"Singh","sequence":"additional","affiliation":[{"name":"Maulana Azad Medical College & Associated Lok Nayak Hospital, New Delhi, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kudyar","family":"Palvi","sequence":"additional","affiliation":[{"name":"Seth GS Medical College and KEM Hospital, Mumbai, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monjori","family":"Mitra","sequence":"additional","affiliation":[{"name":"Institute of Child Health, Kolkata, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ranjitha","family":"Shetty","sequence":"additional","affiliation":[{"name":"Kasturba Medical College, Manipal, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Leclercq","sequence":"additional","affiliation":[{"name":"Aixial, Boulogne-Billancourt, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Venkata Jayanth","family":"Midde","sequence":"additional","affiliation":[{"name":"Sanofi Healthcare India Private Limited, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kucku","family":"Varghese","sequence":"additional","affiliation":[{"name":"Sanofi, Swiftwater, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sreeramulu Reddy","family":"Kandukuri","sequence":"additional","affiliation":[{"name":"Sanofi, Hyderabad, India."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darshna","family":"Kukian","sequence":"additional","affiliation":[{"name":"Sanofi, Hyderabad, India."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Noriega","sequence":"additional","affiliation":[{"name":"Sanofi, Swiftwater, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2023,10,13]]},"reference":[{"key":"R3-20250614","doi-asserted-by":"crossref","first-page":"100137","DOI":"10.1016\/j.jvacx.2021.100137","article-title":"Safety and immunogenicity of a hexavalent DTwP-IPV-HB-PRP~T vaccine versus separate DTwP-HB-PRP~T and IPV vaccines in healthy infants in India.","volume":"10","author":"Mangarule","year":"2022","journal-title":"Vaccine X"},{"key":"R4-20250614","doi-asserted-by":"crossref","first-page":"100190","DOI":"10.1016\/j.jvacx.2022.100190","article-title":"Antibody persistence following administration of a hexavalent DTwP-IPV-HB-PRP~T vaccine versus separate DTwP-HB-PRP~T and IPV vaccines at 12-24 months of age and safety and immunogenicity of a booster dose of DTwP-IPV-HB-PRP~T in healthy infants in India.","volume":"11","author":"Mangarule","year":"2022","journal-title":"Vaccine X"},{"key":"R5-20250614","doi-asserted-by":"crossref","first-page":"100216","DOI":"10.1016\/j.jvacx.2022.100216","article-title":"Lot-to-lot consistency of a hexavalent DTwP-IPV-HB-PRP~T vaccine and non-inferiority to separate DTwP-HB-PRP~T and IPV antigen-matching vaccines at 6-8, 10-12, and 14-16 weeks of age co-administered with oral rotavirus vaccine in healthy infants in India: a multi-center, randomized, controlled study.","volume":"12","author":"Mangarule","year":"2022","journal-title":"Vaccine X"},{"key":"R7-20250614","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4103\/picr.PICR_208_19","article-title":"New drugs and clinical trials rules 2019: Changes in responsibilities of the ethics committee.","volume":"11","author":"Singh","year":"2020","journal-title":"Perspect Clin Res"},{"key":"R8-20250614","doi-asserted-by":"crossref","first-page":"5600","DOI":"10.1016\/j.vaccine.2018.07.048","article-title":"Development and application of a multiplex assay for the simultaneous measurement of antibody responses elicited by common childhood vaccines.","volume":"36","author":"Itell","year":"2018","journal-title":"Vaccine"},{"key":"R9-20250614","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1007\/s40121-021-00530-7","article-title":"A new electrochemiluminescence-based multiplex assay for the assessment of human antibody responses to bordetella pertussis vaccines.","volume":"10","author":"Varghese","year":"2021","journal-title":"Infect Dis Ther"},{"key":"R10-20250614","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I","article-title":"Interval estimation for the difference between independent proportions: comparison of eleven methods.","volume":"17","author":"Newcombe","year":"1998","journal-title":"Stat Med"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004118","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T00:09:29Z","timestamp":1749946169000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,13]]},"references-count":7,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000004118","relation":{},"ISSN":["0891-3668"],"issn-type":[{"type":"print","value":"0891-3668"}],"subject":[],"published":{"date-parts":[[2023,10,13]]}}}